Should mild persistent asthma be treated with rescue albuterol alone?

Article

To assess whether a combination of inhaled beclomethasone plus albuterol could be used as a rescue medication regimen to reduce the frequency of exacerbations, whether the patient also used daily beclomethasone, investigators conducted a trial.

To assess whether a combination of inhaled beclomethasone plus albuterol could be used as a rescue medication regimen to reduce the frequency of exacerbations, whether the patient also used daily beclomethasone, investigators conducted a 44-week trial with 4 treatment groups: twice-daily beclomethasone with beclomethasone plus albuterol as rescue (combined group); twice-daily beclomethasone with placebo plus albuterol as rescue (daily beclomethasone group); twice-daily placebo with beclomethasone plus albuterol as rescue (rescue beclomethasone group); and twice-daily placebo with placebo plus albuterol as rescue (placebo group).

Twice-daily beclomethasone treatment was 1 puff of beclomethasone given in the morning and evening; rescue beclomethasone treatment was 2 puffs of beclomethasone for each 2 puffs of albuterol needed for symptom relief. Exacerbations were defined by a need for a course of oral corticosteroids in addition to the assigned rescue plan. Trial participants were 288 children and adolescents from 5 to 18 years old drawn from 5 clinical centers throughout the country.

By the end of the trial, the probability of a first exacerbation was lowest in the groups that used daily inhaled corticosteroids: 31% in the combined group and 28% in the daily-beclomethasone group. In the rescue-beclomethasone group, that figure was 35%, and it was highest (49%) in the placebo group. During the course of the trial, 29 treatment failures occurred, 60% of which were in the placebo group. Treatment failure was defined as needing a second dose of prednisone within any 6-month period.

Commentary

How many times have you reminded a parent or patient that inhaled steroids are a preventive, not a rescue, medication for asthma? Well, at least for some patients, we may need to change that advice. This study shows that inhaled steroids have a role in preventing asthma exacerbations, even for mild persistent asthma. Adherence to a daily medication for mild asthma is often problematic, however. If patients can't comply with a daily regimen, then addition of inhaled steroids with acute onset of symptoms sometimes may avert a full-blown asthma exacerbation. And this approach may prevent a bit of growth loss as well. -Michael Burke, MD

Recent Videos
Paul Helmuth, MD
Brittany Bruggeman, MD
Octavio Ramilo
Melissa Fickey, MD
Octavio Ramilo, MD
Brittany Bruggeman, MD
John Loiselle, MD
Brittany Bruggeman, MD
Tina Tan, MD, FAAP, FIDSA, FPIDS
© 2024 MJH Life Sciences

All rights reserved.